Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance, (in shares) at Dec. 31, 2020	194,474,000
Beginning balance at Dec. 31, 2020	$ 1,010,968
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of convertible preferred stock to common stock (in shares)	(194,474,000)
Conversion of convertible preferred stock to common stock	$ (1,010,968)
Ending balance, (in shares) at Dec. 31, 2021	0
Ending balance at Dec. 31, 2021	$ 0
Beginning balance, (in shares) at Dec. 31, 2020		15,570,000
Beginning balance at Dec. 31, 2020	(292,528)	$ 2	$ 41,357	$ 256	$ (334,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Proceeds from initial public offering, net of issuance costs (in shares)		25,000,000
Proceeds from initial public offering, net of issuance costs	391,802	$ 2	391,800
Conversion of convertible preferred stock to common stock (in shares)		194,474,000
Conversion of convertible preferred stock to common stock	1,010,968	$ 20	1,010,948
Issuance of common stock upon exercise of stock options (in shares)		2,750,000
Issuance of common stock upon exercise of stock options	9,442		9,442
Stock-based compensation (in shares)		4,944,000
Stock-based compensation	62,201		62,201
Other comprehensive (loss) Income	(1,879)			(1,879)
Net loss	(250,219)				(250,219)
Ending balance, (in shares) at Dec. 31, 2021		242,738,000
Ending balance at Dec. 31, 2021	929,787	$ 24	1,515,748	(1,623)	(584,362)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		3,601,000
Issuance of common stock upon exercise of stock options	9,577	$ 1	9,576
Issuance of common stock under employee stock purchase plan (in share)		475,000
Issuance of common stock under employee stock purchase plan	1,519		1,519
Issuance of common stock in connection with restricted stock units, net of tax (in share)		153,000
Issuance of common stock in connection with restricted stock units, net of tax	(461)		(461)
Stock-based compensation (in shares)		2,600,000
Stock-based compensation	81,924		81,924
Other comprehensive (loss) Income	(5,976)			(5,976)
Net loss	$ (183,118)				(183,118)
Ending balance, (in shares) at Dec. 31, 2022	249,567,343	249,567,000
Ending balance at Dec. 31, 2022	$ 833,252	$ 25	1,608,306	(7,599)	(767,480)
Ending balance, (in shares) at Dec. 31, 2023	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	2,996,262	2,996,000
Issuance of common stock upon exercise of stock options	$ 306		306
Issuance of common stock under employee stock purchase plan (in share)		987,000
Issuance of common stock under employee stock purchase plan	1,894		1,894
Issuance of common stock in connection with restricted stock units, net of tax (in share)		408,000
Issuance of common stock in connection with restricted stock units, net of tax	(457)		(457)
Stock-based compensation	47,084		47,084
Other comprehensive (loss) Income	7,505			7,505
Net loss	$ (234,632)				(234,632)
Ending balance, (in shares) at Dec. 31, 2023	253,957,709	253,958,000
Ending balance at Dec. 31, 2023	$ 654,952	$ 25	$ 1,657,133	$ (94)	$ (1,002,112)